Head of Investor Relations
GeneDx Holdings Corp. (WGS)Equibles does not estimate personal net worth.
Get an email with a short summary when GeneDx Holdings Corp. publishes a filing, an earnings call transcript or a press release.
Get WGS alertsSabrina Dunbar is recorded as Head of Investor Relations at GeneDx Holdings Corp. (WGS). Sabrina Dunbar has spoken on 11 earnings calls across 1 company, most recently for GeneDx Holdings Corp. on November 9, 2026. GeneDx Holdings Corp. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GeneDx Holdings Corp. includes Eric Schadt (CEO and Board Member), Katherine Stueland (CEO and Board Member), Kevin Feeley (CFO) and 7 others.
“On the call, we have Katherine Stuhlund, Chief Executive Officer, Kevin Feely, Chief Financial Officer, and Mark Gardner, President. Earlier today, GNDX released financial results for the third quarter, ended September 30th, 2026.”
“On the call, we have Catherine Stulin, Chief Executive Officer, Kevin Feely, Chief Financial Officer, and Mark Gardner, President. Earlier today, GNDX released financial results for the second quarter ended June 30th, 2026.”
“On the call, we have Catherine Stulin, President and Chief Executive Officer, and Kevin Feeley, Chief Financial Officer. Earlier today, GNDX released financial results for the first quarter ended March 31, 2026.”
“On the call, we have Catherine Stuland, President and Chief Executive Officer, and Kevin Feely, Chief Financial Officer. Earlier today, GNDX released financial results for the fourth quarter ended December 31, 2025.”
“On the call, we have Catherine Stuhlen, President and Chief Executive Officer, Brian Vitero, Chief Operations Officer, and Kevin Feeley, Chief Financial Officer.”
Diagnostics & Research · Healthcare
Head of Investor Relations
